These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. N-alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are high affinity partial agonists at the cloned rat kappa-opioid receptor. Soderstrom K; Choi H; Berman FW; Aldrich JV; Murray TF Eur J Pharmacol; 1997 Nov; 338(2):191-7. PubMed ID: 9456002 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3. Vig BS; Murray TF; Aldrich JV J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314 [TBL] [Abstract][Full Text] [Related]
9. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists. Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590 [TBL] [Abstract][Full Text] [Related]
10. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10. Kawasaki AM; Knapp RJ; Walton A; Wire WS; Zalewska T; Yamamura HI; Porreca F; Burks TF; Hruby VJ Int J Pept Protein Res; 1993 Nov; 42(5):411-9. PubMed ID: 7906258 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs. Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246 [TBL] [Abstract][Full Text] [Related]
12. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency. Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of highly potent and selective cyclic dynorphin A analogues. Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964 [TBL] [Abstract][Full Text] [Related]
14. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors. Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105 [TBL] [Abstract][Full Text] [Related]
15. Binding of dynorphin A and related peptides to kappa- and mu-opioid receptors: sensitivity to Na+ ions and Gpp(NH)p. Gairin JE; Botanch C; Cros J; Meunier JC Eur J Pharmacol; 1989 Oct; 172(4-5):381-4. PubMed ID: 2573538 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues. Story SC; Murray TF; Delander GE; Aldrich JV Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues. Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312 [TBL] [Abstract][Full Text] [Related]
19. Effects of D-amino acid substitution in dynorphin A (1-9) on binding at the mu-, delta- and kappa-sites. Paterson SJ; Kosterlitz HW; Vavrek RJ; Stewart JM Neuropeptides; 1984 Dec; 5(1-3):177-80. PubMed ID: 6152319 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10. Lemaire S; Lafrance L; Dumont M Int J Pept Protein Res; 1986 Mar; 27(3):300-5. PubMed ID: 2872177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]